Roche Holding AG (OTCMKTS:RHHBY) Receives Average Rating of “Hold” from Analysts

Shares of Roche Holding AG (OTCMKTS:RHHBY) have received an average rating of “Hold” from the eleven research firms that are presently covering the stock, Marketbeat.com reports. Six research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $51.50.

Several equities analysts have commented on RHHBY shares. Wolfe Research reiterated an “outperform” rating on shares of Roche in a research report on Thursday, February 26th. Morgan Stanley upgraded shares of Roche from an “underweight” rating to an “equal weight” rating and set a $46.00 price objective for the company in a research report on Friday, April 24th. Finally, Argus raised shares of Roche from a “hold” rating to a “buy” rating in a research note on Monday, April 6th.

Institutional Investors Weigh In On Roche

Several hedge funds and other institutional investors have recently made changes to their positions in RHHBY. Curio Wealth LLC purchased a new stake in shares of Roche in the third quarter valued at $25,000. McIlrath & Eck LLC purchased a new stake in shares of Roche in the first quarter valued at $39,000. Oakworth Capital Inc. raised its stake in shares of Roche by 20.8% in the fourth quarter. Oakworth Capital Inc. now owns 1,658 shares of the company’s stock valued at $86,000 after acquiring an additional 285 shares during the period. Atlas Capital Advisors Inc. purchased a new stake in shares of Roche in the fourth quarter valued at $192,000. Finally, Douglass Winthrop Advisors LLC purchased a new stake in shares of Roche in the third quarter valued at $201,000.

Roche Stock Performance

RHHBY stock opened at $51.65 on Wednesday. Roche has a 52 week low of $37.51 and a 52 week high of $60.85. The company has a current ratio of 1.38, a quick ratio of 1.12 and a debt-to-equity ratio of 0.72. The company has a fifty day simple moving average of $51.06 and a two-hundred day simple moving average of $52.46.

About Roche

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.